100 related articles for article (PubMed ID: 8330873)
1. Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography.
Bares R; Galonska P; Dempke W; Handt S; Büll U; Osieka R
Horm Metab Res Suppl; 1993; 27():56-8. PubMed ID: 8330873
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.
Lipp RW; Silly H; Ranner G; Dobnig H; Passath A; Leb G; Krejs GJ
J Nucl Med; 1995 Jan; 36(1):13-8. PubMed ID: 7799065
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor-based imaging in malignant lymphomas.
O'Brien JP
J Nucl Med; 1995 Jan; 36(1):19-20. PubMed ID: 7799074
[No Abstract] [Full Text] [Related]
4. Somatostatin-receptor imaging in lymphoma.
Goldsmith SJ; Macapinlac HA; O'Brien JP
Semin Nucl Med; 1995 Jul; 25(3):262-71. PubMed ID: 7570045
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor scintigraphy in cutaneous malignant lymphomas.
van den Anker-Lugtenburg PJ; Heule F; Vanhagen PM; van Joost T; Oei HY; Löwenberg B; Krenning EP
J Am Acad Dermatol; 1996 Jun; 34(6):985-93. PubMed ID: 8647992
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma: a comparative study.
Dörr U; Würstlin S; Frank-Raue K; Raue F; Hehrmann R; Iser G; Scholz M; Guhl L; Buhr HJ; Bihl H
Horm Metab Res Suppl; 1993; 27():48-55. PubMed ID: 8330872
[TBL] [Abstract][Full Text] [Related]
7. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis.
Okada J; Yoshikawa K; Imazeki K; Minoshima S; Uno K; Itami J; Kuyama J; Maruno H; Arimizu N
J Nucl Med; 1991 Apr; 32(4):686-91. PubMed ID: 2013808
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor scintigraphy of malignant lymphoma--current status.
Serafini AN
Yale J Biol Med; 1997; 70(5-6):555-9. PubMed ID: 9825483
[No Abstract] [Full Text] [Related]
9. Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markers.
Kälkner KM; Janson ET; Nilsson S; Carlsson S; Oberg K; Westlin JE
Cancer Res; 1995 Dec; 55(23 Suppl):5801s-5804s. PubMed ID: 7493349
[TBL] [Abstract][Full Text] [Related]
10. Visualization of non-Hodgkin's lymphoma by high dosed somatostatin receptor specific scintigraphy and extended single photon emission tomography.
Lipp RW; Schnedl WJ; Aglas F; Ranner G; Beham-Schmid C; Leb G; Sill H
Acta Med Austriaca; 1999; 26(3):105-8. PubMed ID: 10520379
[TBL] [Abstract][Full Text] [Related]
11. [Somatostatin receptor scintigraphy in preoperative diagnosis of the site of endocrine gastrointestinal tumors].
Weinel RJ; Kisker O; Joseph K; Welcke U; Zaraca F; Rothmund M
Chirurg; 1994 Oct; 65(10):849-55. PubMed ID: 7821043
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptor scintigraphy in brain tumors and pituitary tumors: first experiences.
Scheidhauer K; Hildebrandt G; Luyken C; Schomäcker K; Klug N; Schicha H
Horm Metab Res Suppl; 1993; 27():59-62. PubMed ID: 8330874
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET for predicting the prognosis of malignant lymphoma.
Okada J; Oonishi H; Yoshikawa K; Itami J; Uno K; Imaseki K; Arimizu N
Ann Nucl Med; 1994 Aug; 8(3):187-91. PubMed ID: 7811561
[TBL] [Abstract][Full Text] [Related]
14. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.
Lewis PJ; Salama A
J Nucl Med; 1994 Oct; 35(10):1647-9. PubMed ID: 7931664
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of 111In-octreotide scans in CNS tumors.
Sciuto R; Ferraironi A; Semprebene A; Occhipinti E; Mastrostefano R; Crecco M; Mottolese M; Maini CL
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):101-3. PubMed ID: 9002762
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogue scintigraphy of malignant lymphomas.
Vanhagen PM; Krenning EP; Reubi JC; Mulder AH; Bakker WH; Oei HY; Löwenberg B; Lamberts SW
Br J Haematol; 1993 Jan; 83(1):75-9. PubMed ID: 8094627
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas.
Lugtenburg PJ; Löwenberg B; Valkema R; Oei HY; Lamberts SW; Eijkemans MJ; van Putten WL; Krenning EP
J Nucl Med; 2001 Feb; 42(2):222-9. PubMed ID: 11216520
[TBL] [Abstract][Full Text] [Related]
18. The use of PET-18FDG imaging in the clinical evaluation of head and neck lymphoma.
Walsh RM; Wong WL; Chevretton EB; Beaney RP
Clin Oncol (R Coll Radiol); 1996; 8(1):51-4. PubMed ID: 8688363
[TBL] [Abstract][Full Text] [Related]
19. Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy.
Hoekstra OS; Ossenkoppele GJ; Golding R; van Lingen A; Visser GW; Teule GJ; Huijgens PC
J Nucl Med; 1993 Oct; 34(10):1706-10. PubMed ID: 8410287
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas.
Reubi JC; Waser B; van Hagen M; Lamberts SW; Krenning EP; Gebbers JO; Laissue JA
Int J Cancer; 1992 Apr; 50(6):895-900. PubMed ID: 1348240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
